Login to Your Account



Earnings Roundup

Genzyme's First-Quarter Sales Below Expectations

By Randall Osborne


Thursday, April 20, 2006
Genzyme Corp.'s stock dipped on word that first-quarter revenues came in lower than expected, though the $730.8 million number represents a 16 percent rise over the same quarter last year. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription